• Profile
Close

Postoperative enteral nutrition guidelines reduce the risk of intestinal failure–associated liver disease in surgical infants

The Journal of Pediatrics Feb 09, 2018

Shores DR, et al. - The effectiveness of postoperative feeding guidelines in reducing the incidence and severity of intestinal failure–associated liver disease (IFALD) among infants was determined. Implementation of feeding guidelines resulted in a reduction in time to reach feeding goals, thereby significantly reducing the incidence and severity of IFALD.

Methods

  • Researchers performed a comparison of two cohorts of infants <6 months old undergoing intestinal surgery: preguideline (retrospective data from 2007 to 2013; n = 83) and postguideline (prospective data from 2013 to 2016; n = 81).
  • Greater initial enteral nutrition volumes of 20 mL/kg/d and daily feeding advancement if tolerated were included in guidelines.
  • Incidence of IFALD (peak direct bilirubin [DB] >2 mg/dL) and severity (DB >5 mg/dL for moderate-severe) were the primary outcomes assessed.
  • They used multiple logistic regression to ascertain the odds of developing IFALD.
  • Time to reach 50% and 100% goal calories from enteral nutrition and the incidence of necrotizing enterocolitis after feeding were the other assessed outcomes.

Results

  • A decrease in the incidence of IFALD from 71% to 51% (P=.031), and in median peak DB from 5.7 to 2.4 mg/dL (P=.001) was noticed.
  • With guideline use, a reduction in the odds of developing IFALD of any severity by 60% (OR 0.40, 95% CI 0.20-0.85), and in the odds of developing moderate-to-severe IFALD by 72% (OR 0.28, 95% CI 0.13-0.58) was noticed after adjusting for diagnosis and prematurity.
  • In this study, time to reach 50% enteral nutrition reduced from a median of 10 to 6 days (P=.020) and time to reach 100% enteral nutrition reduced from 35 to 21 days (P=.035) with guideline use.
  • No change in the incidence of necrotizing enterocolitis after initiating enteral nutrition was noticed (5% vs 9%, P=.346).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay